Nuo Therapeutics Inc
OTC:AURX

Watchlist Manager
Nuo Therapeutics Inc Logo
Nuo Therapeutics Inc
OTC:AURX
Watchlist
Price: 1.9 USD -0.52% Market Closed
Market Cap: 91.4m USD

Operating Margin
Nuo Therapeutics Inc

-98.3%
Current
-1 163%
Average
6.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-98.3%
=
Operating Profit
-2.6m
/
Revenue
2.6m

Operating Margin Across Competitors

No Stocks Found

Nuo Therapeutics Inc
Glance View

Market Cap
89m USD
Industry
N/A

Nuo Therapeutics, Inc. is a biomedical company. The company is headquartered in Houston, Texas and currently employs 7 full-time employees. The company went IPO on 2017-01-19. The firm's Aurix System is a biodynamic hematogel that harnesses a patient's innate regenerative abilities for the management of a variety of wounds. The firm commercializes cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing. The Company’s Aurix point of care technology for the safe and efficient separation of autologous blood to produce a platelet-based therapy for the chronic wound care market. The firm is marketing its products primarily within the United States. Nuo Therapeutics' s Aurix System produces a platelet rich plasma (PRP), gel at the point of care using the patient’s own platelets and plasma. The Aurix comprises a natural, endogenous complement of protein and non-protein signal molecules that contribute to effective healing.

AURX Intrinsic Value
0.4 USD
Overvaluation 79%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-98.3%
=
Operating Profit
-2.6m
/
Revenue
2.6m
What is the Operating Margin of Nuo Therapeutics Inc?

Based on Nuo Therapeutics Inc's most recent financial statements, the company has Operating Margin of -98.3%.

Back to Top